Home > Insider Trading > Filing (0001562180-15-000273)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1271214	Intersect Ent Inc.	XENT	Surgical & Medical Instruments & Apparatus (3841)	200280837

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1614586	Amy Wolbeck	C/O Intersect Ent, Inc. 1555 Adams Drive Menlo Park CA 94025	V.p. Regulatory Affairs & Qlty	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-04-13	7,500	$0.72	7,500	No	4	M	Direct
Common Stock	Acquisiton	2015-04-13	4,401	$1.00	11,901	No	4	M	Direct
Common Stock	Acquisiton	2015-04-13	4,099	$0.72	16,000	No	4	M	Direct
Common Stock	Disposition	2015-04-13	16,000	$26.25	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-04-13	4,401	$0.00	4,401	$1.00
Common Stock	Stock Option (right to buy)	Disposition	2015-04-13	7,500	$0.00	7,500	$0.72
Common Stock	Stock Option (right to buy)	Disposition	2015-04-13	4,099	$0.00	4,099	$0.72

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2019-02-02	No	4	M	Direct
0	2020-08-02	No	4	M	Direct
18,401	2021-01-31	No	4	M	Direct

Footnotes

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 8, 2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.56 to $26.86, inclusive. The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
The shares subject to this option are immediately exercisable. 25% of the shares subject to the option vested on January 5, 2010 and 1/48th of the shares subject to the option vests monthly thereafter over three (3) years.
The shares subject to the option are fully vested on August 3, 2010 grant date.
The shares subject to the option are immediately exercisable. 1/48th of the shares subject to the option vest monthly over 48 months beginning March 1, 2011.